Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Once cautious, OpenAI, Grok, and others will now dive into giving unverified medical advice with virtually no disclaimers.

Most U.S. adults find the information to be at least somewhat reliable, new research shows. But experts say there is ...

Google DeepMind researchers believe that by building for India's linguistic, economic, and cultural complexity, their work ...

If agentic AI is to be successful, companies will have to figure out how to protect data. With that in mind, several big tech players now offer their own flavor of confidential computing.

Google has expanded NotebookLM to allow sharing of notebooks, and more importantly, access to curated collections from ...

Google's new AI features, automated business calls, Gemini 2.5 Pro, and Deep Search, enhancing everyday Search for US users.

At least 15,000 healthcare professionals across Vietnam will benefit from the “AI Opportunity for Healthcare Professionals” ...

Although patients and the general public were identified as the primary audience, the researchers noted that AI-generated podcasts could serve as a cost-effective, scalable way for healthcare ...

Google DeepMind subsidiary, Isomorphic Labs, has said it is ready to conduct human trials for drugs developed using its AlphaFold AI technology.

MedGemma 27B Multimodal and MedSigLIP are unique not because they can be downloaded and modified by hospitals on a smartphone ...